E
Neumora Therapeutics, Inc. NMRA
$1.28 -$0.12-8.57%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 37.52% 37.00% 63.66% 53.16% 46.12%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 40.00% 48.47% 61.95% 58.65% 53.17%
Operating Income -40.00% -48.47% -61.95% -58.65% -53.17%
Income Before Tax -3.37% -88.78% -107.95% -105.49% -80.02%
Income Tax Expenses -33.58% -- -- -- --
Earnings from Continuing Operations -3.33% -89.07% -108.25% -105.71% -80.23%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -3.33% -89.07% -108.25% -105.71% -80.23%
EBIT -40.00% -48.47% -61.95% -58.65% -53.17%
EBITDA -40.16% -48.67% -62.20% -58.87% -53.36%
EPS Basic 64.79% 59.46% 43.84% 21.28% 10.29%
Normalized Basic EPS 61.05% 68.57% 53.09% 30.83% 9.65%
EPS Diluted 64.79% 59.46% 43.84% 21.28% 10.29%
Normalized Diluted EPS 61.05% 68.57% 53.09% 30.83% 9.65%
Average Basic Shares Outstanding 146.21% 368.26% 347.71% 245.82% 137.95%
Average Diluted Shares Outstanding 146.21% 368.26% 347.71% 245.82% 137.95%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings